首页> 外文OA文献 >Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes

【2h】

Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes

机译：白细胞介素-2（IL-2）接受免疫疗法的癌症患者的补体激活：IL-2活化淋巴细胞的补体和C-反应蛋白的结合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
G Vachino; JA Gelfand; MB Atkins; JD Tamerius; P Demchak; JW Mier;
展开▼
作者单位

展开▼
年度 1991
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro. [J] . Bruins P, te-Velthuis H, Eerenberg-Belmer AJ, Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2000,第2期

机译：肝素-鱼精蛋白复合物和C反应蛋白诱导经典补体途径的激活：在接受心脏手术和体外试验的患者中进行的研究。
2. Immunotherapy with interleukin-2 and alpha-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer. [J] . Meehan KR, Arun B, Gehan EA, Bone marrow transplantation . 1999,第7期

机译：IL-2激活的造血干细胞移植后乳腺癌白细胞介素2和α干扰素的免疫治疗。
3. Factor H-related protein 1 (FHR-1) binds to C-reactive protein and enhances complement activation via competition with factor H and binding C3b [J] . Csincsi Adam I., Banlaki Zsofia, Weiszhar Zsoka, Molecular Immunology . 2015,第1期

机译：H因子相关蛋白1（FHR-1）与C反应蛋白结合并通过与H因子竞争和结合C3b增强补体激活
4. Humanized Recombinant Vaccinia Virus Complement Control Protein (hrVCP) with Three Amino Acid Changes, H98Y, E102K, and E120K Creating an Additional Putative Heparin Binding Site, Is 100-fold More Active Than rVCP in Blocking Both Classical and Alternative Complement Pathways [C] . YOHANNES T. GHEBREMARIAM, ODUTAYO O. ODUNUGA, KRISTEN JANSE, International Conference on Natural Products and Molecular Medicine . 2005

机译：人源化重组疫苗病毒补蛋白（HRVCP）具有三个氨基酸变化，H98Y，E102K和E120K产生另外的肝素结合位点，比RVCP在阻断经典和替代的补体途径时，100倍。
5. EFFECTS OF C-REACTIVE PROTEIN BINDING TO NUCLEATED CELLS ON SELECTED HOST DEFENSE MECHANISMS (COMPLEMENT PATHWAY). [D] . MOTAMENI, SHIVA. 1985

机译：C阳性蛋白与核细胞结合对选定的宿主防御机制（补体途径）的影响。
6. Evidence that induction and regulation of lymphokine-activated killer (LAK) activity are mediated by changes in tumour-binding potential of lymphocytes after activation by interleukin-2 (IL-2). [O] . A Uchiyama, T Morisaki, M Torisu 1991

机译：有证据表明白介素2（IL-2）激活后淋巴细胞的肿瘤结合潜能的变化介导了淋巴因子激活的杀手（LAK）活性的诱导和调节。
7. Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein [O] . Sjöberg, Andreas P., Trouw, Leendert A., McGrath, Fabian D. G., 2006

机译：C反应蛋白对补体激活的调节：靶向C4b结合蛋白的抑制活性

Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes

著录项

引文网络

相似文献

相关主题

期刊订阅